Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 11.83 Billion | USD 23.08 Billion | 6.4% | 2024 |
The global orthopedic trauma devices market size was worth around USD 11.83 Billion in 2024 and is predicted to grow to around USD 23.08 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 6.4% between 2025 and 2034. The report analyzes the global orthopedic trauma devices market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the orthopedic trauma devices industry.
Any serious injury to the bones, joints, or soft tissue that results from an external source is referred to as orthopedic trauma. These injuries are frequently brought on by an unexpected event, such as a vehicle accident or slip and fall, but not necessarily. Excessive use can also result in trauma; for instance, long-distance running frequently results in tibial stress fractures, which are minute hairline cracks in the lower leg. Orthopedic trauma devices are used to fix shattered bones and help restore the anatomic alignment of joint surfaces, enabling regeneration and the restoration of the afflicted body part's full functionality. Among the tools and instruments used in reconstructive surgery are screws, plate systems, intramedullary nails, and specialized implants. Titanium, stainless steel, and other materials are frequently used in the manufacture of these devices. Orthopedic trauma is treated with polylactic acid and polyglycolic acid.
Increasing road accidents across the globe drive market expansion
The increasing number of road accidents across the globe is expected to flourish the global orthopedic trauma devices market growth during the forecast period. According to "Road Accidents in India 2021," there were 4,12,432 road accident incidents in 2021, which resulted in 1,53,972 fatalities and 3,84,448 injuries. Moreover, as per the data from the World Health Organization, the lives of almost 1.3 million individuals are cut short annually as a result of traffic accidents. There are an additional 20 to 50 million people who sustain non-fatal injuries, many of whom go on to develop disabilities. Thus, these stats support the market revenue growth during the forecast period.
High costs and limited reimbursements hamper the market growth
Orthopedic trauma devices, particularly cutting-edge implants and tools, can be expensive. Some individuals and healthcare systems may not be able to afford these therapies, especially in areas with limited healthcare resources. Furthermore, orthopedic trauma devices may not always be fully covered by reimbursement programs. This may have an impact on patient affordability and discourage healthcare organizations from implementing the latest, most advanced technology. Thus, this is expected to act as a major restraining factor to the orthopedic trauma devices industry growth during the forecast period.
Growing regulatory approval offers an attractive opportunity for market growth
The growing regulatory approvals are expected to offer an attractive opportunity for orthopedic trauma devices market growth during the forecast period. For instance, in March 2023, the FDA granted market authorization for Bioretec Ltd's revolutionary RemeOsTM trauma screw, which will be utilized for the repair of bone fractures in line with the clinical study. Bioretec Ltd. is a pioneer in bioresorbable orthopedic implants. The United States, the world's largest single market for orthopedic trauma products, is where bioresorbable metal implants were initially introduced and are now solely offered by Bioretec. By making conventional titanium and steel implants superfluous, the RemeOsTM trauma screw promises to do away with the requirement for implant removal surgery. RemeOsTM strengthens the value offered for patients with ankle fractures while assisting orthopedic clinics in attaining their operational and healthcare objectives. Thereby, driving the market growth.
Stringent regulatory approval poses a challenge to market growth
Devices for orthopedic trauma might take an extended period and funds to receive regulatory clearance. Before their products can enter the market, manufacturers must adhere to strict regulations and go through significant testing, which can delay product introductions. Thus, the stringent regulatory approval poses a major challenge to the market growth during the forecast period.
The global Orthopedic Trauma Devices industry is segmented based on type, material, end user, and region.
Based on the type, the global market is bifurcated into internal fixators and external fixators. The external fixators segment is expected to capture the largest market share over the forecast period. Medical devices known as external fixators are used to immobilize and stabilize broken bones, dislocated joints, and soft tissue injuries without internal support. They are made up of surgically implanted rods or pins made of metal or carbon fiber that are placed into the bone on each side of the fracture. These pins are attached to an external frame that maintains the bones in the proper alignment so that they may mend properly. External fixators are essential medical devices used in orthopedic trauma treatment because they offer patients with severe injuries and fractures instant stabilization and support. They help patients recover more quickly and with fewer problems due to the advancements made possible by their ongoing research and improvement. Thereby, driving the segment expansion.
Based on the material, the global orthopedic trauma devices market is bifurcated into metallic and bioabsorbable.
Based on the end user, the orthopedic trauma devices industry is bifurcated into hospitals, ambulatory centers, orthopedic & trauma centers, and others. The hospital segment is expected to dominate the market during the forecast period. There are more hospitals, which results in shorter wait times for patients and better hospital infrastructure along with appropriate care for trauma injuries. Increasing government funding is being provided to hospitals for the provision of equipment and fair reimbursement practices. Thereby, driving the segment growth.
Report Attributes | Report Details |
---|---|
Report Name | Orthopedic Trauma Devices Market |
Market Size in 2024 | USD 11.83 Billion |
Market Forecast in 2034 | USD 23.08 Billion |
Growth Rate | CAGR of 6.4% |
Number of Pages | 221 |
Key Companies Covered | B. Braun Melsungen AG, Stryker, Smith & Nephew plc, Medical Devices Business Services Inc., Zimmer Biomet, CONMED Corporation, Citieffe s.r.l., Acumed LLC, Integra LifeSciences Corporation, Orthofix Holdings Inc., Biotek, Wright Medical Group N.V., Invibio Ltd, Auxein Medical, Medtronic, NuVasive Inc, 3M, ALCARE Co. Ltd., Bauerfeind USA Inc., and others., and others. |
Segments Covered | By Product Type, By Material, By End-user, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2023 |
Forecast Year | 2025 - 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is expected to dominate the market growth over the forecast period
North America is expected to dominate the global orthopedic trauma devices market during the forecast period. The rise in geriatric patients and the rising prevalence of osteoporosis and other bone diseases drive the market growth over the forecast period. Osteoporosis is predicted to affect 12.3 million Americans over the age of 50 in 2020, which is projected to fuel market expansion throughout the projection period. This prediction comes from JAMA (The Journal of the American Medical Association). Moreover, the Centers for Disease Control and Prevention also reported in May 2020 that unintentional injuries were responsible for 169,936 annual fatalities, 39.5 million doctor visits, and 29.4 million visits to emergency rooms in the United States. Thus, it is anticipated that the aforementioned attributes will continue to flourish in market expansion.
On the other hand, the Asia Pacific is expected to grow at the highest CAGR during the forecast period. The two countries with the largest populations of senior citizens are likely to be China and India. As a result, it is projected that these countries' demand will rise considerably soon. Due to the accessible and inexpensive nature of cutting-edge medical treatments, it is also projected that the growing medical tourism industry will attract more patients from the target patient category. Japan spends more on healthcare and has more implant manufacturers than the majority of other countries in its area. In addition, it's projected that widespread use of new technologies would encourage regional market growth.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the orthopedic trauma devices market on a global and regional basis.
The global orthopedic trauma devices market is dominated by players like:
The global orthopedic trauma devices market is segmented as follows;
By Product Type
By Material
By End-user
By Region
FrequentlyAsked Questions
Any serious injury to the bones, joints, or soft tissue that results from an external source is referred to as orthopedic trauma. These injuries are frequently brought on by an unexpected event, such as a vehicle accident or slip and fall, but not necessarily. Excessive use can also result in trauma; for instance, long-distance running frequently results in tibial stress fractures, which are minute hairline cracks in the lower leg. Orthopedic trauma devices are used to fix shattered bones and help restore the anatomic alignment of joint surfaces, enabling regeneration and the restoration of the afflicted body part's full functionality.
The global orthopedic trauma devices market is expected to grow due to Rising incidence of fractures and accidents, along with aging populations, fuels demand. Advancements in minimally invasive and biodegradable implants support growth.
According to a study, the global orthopedic trauma devices market size was worth around USD 11.83 Billion in 2024 and is expected to reach USD 23.08 Billion by 2034.
The global orthopedic trauma devices market is expected to grow at a CAGR of 6.4% during the forecast period.
The global Orthopedic Trauma Devices market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market due to the presence of major market players and a growing aging population.
Leading players in the global orthopedic trauma devices market include B. Braun Melsungen AG, Stryker, Smith & Nephew plc, Medical Devices Business Services Inc., Zimmer Biomet, CONMED Corporation, Citieffe s.r.l., Acumed LLC, Integra LifeSciences Corporation, Orthofix Holdings Inc., Biotek, Wright Medical Group N.V., Invibio Ltd, Auxein Medical, Medtronic, NuVasive Inc, 3M, ALCARE Co. Ltd., Bauerfeind USA Inc., and others., among others.
The report explores crucial aspects of the orthopedic trauma devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed